Sun Pharma and Moebius Medical's MM-II for Osteoarthritis Gets FDA Fast Track Nod Sept. 6, 2024, 12:14 p.m. Sun Pharma and Moebius Medical announced FDA Fast Track designation for MM-II, a treatment for osteoarthritis knee pain.Fast Track designation helps expedite the development and revi… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More